As per the NHS target, 95% people suspected with cancer should have a meeting with a specialist within two weeks. But as per the figures by the NHS England, it has been unveiled that there are thousands of people who are not being referred to specialists in the above mentioned timeframe.
The figures in the report have found that of the 4,000 GP surgeries, over 50% have not met the target. The report has been publicized after Health Secretary Jeremy Hunt affirmed that every patient should be provided with best care.
He has been coming with certain changes in order to improve the level of care being provided to patients. It has been found that inspection system will be carried out for GPs.
"Every single patient in the NHS has a right to the very best care - and to see a GP who can spot cancer symptoms early enough to make a difference", affirmed Hunt.
It has been found that the NHS England has gathered data from GP surgeries that were carried out across the nation. The main aim of coming up with the report is to bring increased level of transparency in health service.
On Tuesday, HTC released a statement to announce the launch of a $100 million fund, Vive X. The fund has been designed with the key objective of promoting the growth of startups focused on virtual reality (VR) across the world.
According...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
China's Dakang Australia has been looking forward to sign a deal to buy Kidman, one of the Australia's biggest beef producers and owner of farm assets. However, the deal could be cancelled as the Australian government said it found that selling...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
At the PAX East event this weekend, Harmonix laid down...
A new first-person shooter game was announced by Doom...
In a recent announcement, Amazon has revealed that it...
Sirin Labs, a 2013-founded stealth Israeli startup, has...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).
